Fundraising FoxScientia Ventures — 2014 Investments
3 investments dated 2014 · listed companies and verified rows first · show all
Cibus develops crops using a proprietary gene-editing technology that reproduces nature's own genetic blueprints to add specific traits, such as resistance to heat, pests, fungus, and weeds.
AgTechBiotechClimate TechSan Diego, US
Peter Beetham(Chief Executive Officer)inRory Riggs(Chairman of the Board)Keith Walker, Ph.D.(President)LaDon Johnson(Executive Officer)in
BoardAlain Pompidou(Director)
Board seatMark FinnRory Riggs· per SEC Form D
eReceivables is a healthcare revenue recovery firm that specializes in identifying and resolving underpaid, denied, and overlooked insurance claims for hospitals and healthcare systems.
Enterprise SoftwareFintechHealthtechSaaSHollywood, US
William Whitaker(Chief Operating Officer)Gil Perry(Executive Officer)Steven Griffin(President)
BoardBarbara Rohan(Director)
Board seatRory RiggsJonathan Finn· per SEC Form D
Kyntra Bio (formerly FibroGen) is a clinical-stage biopharmaceutical company developing therapies for oncology and rare diseases, including serious and life-threatening conditions.
BiotechHealthtechSan Francisco, US
Thomas B. Neff(Executive Officer, Director)Frank H. Valone(Executive Officer)inK. Peony Yu(Executive Officer)inPat Cotroneo(Executive Officer)inRory Riggs(Founder)
BoardRory B. Riggs(Director)
Co-investorsAvalon BioVenturesForesite CapitalRidgeback CapitalMaverick Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.